Pilates in Ankylosing Spondylitis

Sponsor
Pamukkale University (Other)
Overall Status
Completed
CT.gov ID
NCT05987111
Collaborator
(none)
20
1
2
6.3
3.2

Study Details

Study Description

Brief Summary

This study was planned to examine and compare the effectiveness of two different pilates exercise methods (mat pilates vs reformer pilates) in individuals with Ankylosing Spondylitis(AS).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Pilates
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Comparison of Efficacy of Two Different Pilates Exercise Methods in Individuals With Ankylosing Spondylitis: A Randomized Controlled Study
Actual Study Start Date :
Aug 2, 2022
Actual Primary Completion Date :
Dec 15, 2022
Actual Study Completion Date :
Feb 10, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Mat Pilates

Mat Pilates Exercises

Behavioral: Pilates
Pilates exercises were applied twice a week for 4 weeks in both groups. The sessions were supervised by an Australian Physiotherapy and Pilates Institute (APPI) certified physiotherapist as 5 minutes of warm-up, 45 minutes of exercise and 5 minutes of cool-down periods.

Experimental: Reformer Pilates

Reformer Pilates Exercises

Behavioral: Pilates
Pilates exercises were applied twice a week for 4 weeks in both groups. The sessions were supervised by an Australian Physiotherapy and Pilates Institute (APPI) certified physiotherapist as 5 minutes of warm-up, 45 minutes of exercise and 5 minutes of cool-down periods.

Outcome Measures

Primary Outcome Measures

  1. Bath Ankylosing Spondylitis Metrology Index [10 minutes]

    This index consists of 5 measurements: cervical rotation, tragus to wall distance, lumbar side flexion, modified Schober's, intermalleolar distance.

  2. Bath Ankylosing Spondylitis Disease Activity Index [5minutes]

    BASDAI consists of 6 questions evaluating the patient's level of weakness/fatigue, spinal pain, joint pain/swelling and sensitivity to touch, and duration of morning stiffness in the last week.

  3. Bath Ankylosing Spondylitis Functional Index (BASFI) [5 minutes]

    This scale, which evaluates the functional limitation of AS patients in activities of daily living, consists of 10 questions.

  4. Ankylosing Spondylitis Quality of Life Questionnaire [5 minutes]

    This questionnaire, which evaluates disease-specific quality of life, consists of 18 questions

  5. Maastrich Ankylosing Spondylitis Enthesitis Score [5minutes]

    Its validity and reliability were defined to evaluate enthesopathy and peripheral joint involvement.

  6. Multidimensional Assessment of Fatigue Scale [5 minutes]

    MAF scale evaluates the level of fatigue during daily activities in the last week.

  7. Biopsychosocial Questionnaire (BETY-BQ) [10minutes]

    The BETY-BQ evaluates the biopsychosocial status of patients with rheumatic diseases.

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Being in the age range of 20-65, using stable medication for at least 3 months, being sedentary (Not regularly participating in exercise activities for the past 3 months).
Exclusion Criteria:
  • the presence of cardiovascular, pulmonary, orthopedic and neurological problems, another rheumatic disease, being pregnant, inability to participate in at least 75% of the exercises.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Usak University Usak Merkez Turkey 64200

Sponsors and Collaborators

  • Pamukkale University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Elif Gur Kabul, principal investigator, Uşak University
ClinicalTrials.gov Identifier:
NCT05987111
Other Study ID Numbers:
  • Exercise
First Posted:
Aug 14, 2023
Last Update Posted:
Aug 15, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 15, 2023